Literature DB >> 33725243

Content of Peripheral Blood T- and B-Cell Subpopulations in Transgenic A53T Mice of Different Age (A Model of Parkinson's Disease).

G V Idova1, E L Al'perina2, M M Gevorgyan2, M A Tikhonova2, S Ya Zhanaeva2.   

Abstract

We analyzed the behavior and peripheral blood T- and B-cell subpopulations in mice overexpressing the mutant form of human α-synuclein (A53T) in comparison with mice of the wild type (WT) parent C57BL/6J strain. Behavioral phenotype and the content of various cell subpopulations of A53T mice depended on animal age. Young (2-month-old mice) were characterized by low emotionality and the most pronounced changes in cell subpopulation composition (an increase in CD3+T cells and CD4+T helper cells, a decrease in CD19+B cells along with unchanged content of CD3+CD4+CD25+T-regulatory cells and CD19+CD25+B-regulatory cells). In old A53T mice (10-month-old), movement impairments appeared and increased numbers of CD4+T helper cells and CD3+CD4+CD25+T-regulatory cells were revealed.

Entities:  

Keywords:  Parkinson’s disease; aging; behavior; mice А53Т; Т- and В-cell subpopulations

Year:  2021        PMID: 33725243     DOI: 10.1007/s10517-021-05075-w

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  12 in total

Review 1.  Neuroinflammation in Parkinson's disease.

Authors:  Etienne C Hirsch; Sheela Vyas; Stéphane Hunot
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  Alterations of T-lymphocyte populations in Parkinson disease.

Authors:  Yasuhiko Baba; Ataru Kuroiwa; Ryan J Uitti; Zbigniew K Wszolek; Tatsuo Yamada
Journal:  Parkinsonism Relat Disord       Date:  2005-09-09       Impact factor: 4.891

3.  Peripheral Lymphocyte Subsets as a Marker of Parkinson's Disease in a Chinese Population.

Authors:  Luan Cen; Chaohao Yang; Shuxuan Huang; Miaomiao Zhou; Xiaolu Tang; Kaiping Li; Wenyuan Guo; Zhuohua Wu; Mingshu Mo; Yousheng Xiao; Xiang Chen; Xinling Yang; Qinhui Huang; Chaojun Chen; Shaogang Qu; Pingyi Xu
Journal:  Neurosci Bull       Date:  2017-08-08       Impact factor: 5.203

4.  Th17 cells: a promising therapeutic target for Parkinson's disease?

Authors:  Iryna Prots; Beate Winner
Journal:  Expert Opin Ther Targets       Date:  2019-03-14       Impact factor: 6.902

5.  A dysfunction of CD4+ T lymphocytes in peripheral immune system of Parkinson's disease model mice.

Authors:  Yan Huang; Zhan Liu; Xiao-Qin Wang; Yi-Hua Qiu; Yu-Ping Peng
Journal:  Zhongguo Ying Yong Sheng Li Xue Za Zhi       Date:  2014-11

6.  Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.

Authors:  Vanessa Brochard; Béhazine Combadière; Annick Prigent; Yasmina Laouar; Aline Perrin; Virginie Beray-Berthat; Olivia Bonduelle; Daniel Alvarez-Fischer; Jacques Callebert; Jean-Marie Launay; Charles Duyckaerts; Richard A Flavell; Etienne C Hirsch; Stéphane Hunot
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

7.  Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.

Authors:  Hui-Ming Gao; Feng Zhang; Hui Zhou; Wayneho Kam; Belinda Wilson; Jau-Shyong Hong
Journal:  Environ Health Perspect       Date:  2011-01-18       Impact factor: 9.031

8.  Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.

Authors:  Janelle Drouin-Ouellet; Isabelle St-Amour; Martine Saint-Pierre; Jérôme Lamontagne-Proulx; Jasna Kriz; Roger A Barker; Francesca Cicchetti
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-07       Impact factor: 5.176

Review 9.  T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases.

Authors:  Hugo González; Rodrigo Pacheco
Journal:  J Neuroinflammation       Date:  2014-12-02       Impact factor: 8.322

Review 10.  Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies.

Authors:  Violetta Refolo; Nadia Stefanova
Journal:  Front Cell Neurosci       Date:  2019-06-13       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.